Cargando…
New Therapeutic Options for Type 2 Diabetes Mellitus and Their Impact Against Ischemic Heart Disease
Type 2 diabetes mellitus (T2DM) greatly increases risk for cardiovascular disease, including ischemic heart disease and myocardial infarction. With the completion of several cardiovascular outcomes trials (CVOTs) for new glucose-lowering therapies, including the sodium-glucose cotransporter-2 (SGLT2...
Autores principales: | Almutairi, Malak, Chan, Jordan S. F., Ussher, John R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271769/ https://www.ncbi.nlm.nih.gov/pubmed/35832485 http://dx.doi.org/10.3389/fphys.2022.904626 |
Ejemplares similares
-
Myocardial Energy Metabolism in Non-ischemic Cardiomyopathy
por: Greenwell, Amanda A., et al.
Publicado: (2020) -
The Impact of Antidiabetic Therapies on Diastolic Dysfunction and Diabetic Cardiomyopathy
por: Gopal, Keshav, et al.
Publicado: (2020) -
Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022) -
Exosomes: Basic Biology and Technological Advancements Suggesting Their Potential as Ischemic Heart Disease Therapeutics
por: Shanmuganathan, Mayooran, et al.
Publicado: (2018) -
Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
por: Dhore-patil, Aneesh, et al.
Publicado: (2022)